In fact, GnRH analogs demonstrated their efficacy in the presurgical treatment of fibroids [60] and several studies have shown how the presurgical use of GnRH analogs, in addition to the aforementioned effects, decreases endometrial thickness and impairs fibroid vascularization, thus reducing surgical blood loss [61]. The gene discussed is GNRH1; the disease is leiomyoma.